Shenglin Ma
Overview
Explore the profile of Shenglin Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
210
Citations
2582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chen W, Ma S, Lai X, Wang Z, Zhao H, Zha Q, et al.
Micromachines (Basel)
. 2024 Jun;
15(6).
PMID: 38930750
To address the requirements of sonar imaging, such as high receiving sensitivity, a wide bandwidth, and a wide receiving angle, an AlN PMUT with an optimized ratio of 0.6 for...
12.
Huang J, Xu Y, Chen Y, Shen J, Qiu Y, Li X, et al.
J Transl Med
. 2024 May;
22(1):500.
PMID: 38797856
No abstract available.
13.
Zhang J, Li L, Luo W, Ma S, Zhao Y
Clin Transl Oncol
. 2024 May;
26(12):2979-2992.
PMID: 38776034
Background: The aim of this study is to explore the prognostic value and immune signature of ITGB4 expression in lung adenocarcinoma (LUAD) brain metastasis. Methods: We comprehensively screened genes associated...
14.
Xu C, Wang Q, Wang D, Wang W, Fang W, Li Z, et al.
Glob Med Genet
. 2024 Feb;
11(1):86-99.
PMID: 38414979
The fusion genes and , members of the epidermal growth factor (EGF) receptor family, have emerged as key drivers in cancer. Upon fusion, retains its EGF-like active domain, binds to...
15.
Chen T, Duan Y, Dai W, Guo W, Jing P, Ma S, et al.
J Colloid Interface Sci
. 2024 Feb;
663:396-404.
PMID: 38412725
The lack of selective release ability in the tumor microenvironment and the limited efficacy of monotherapy are important factors that limit the current use of carbon monoxide (CO) donors for...
16.
Kong W, Liu X, Zhu H, Zheng S, Yin G, Yu P, et al.
Aging (Albany NY)
. 2024 Jan;
16(2):1767-1780.
PMID: 38244583
Approximately 10% of gastric cancers are associated with Epstein-Barr virus (EBV). polysaccharides (TFPs) are characterized by antioxidative and anti-inflammatory effects in different diseases. However, whether TFP improves EBV-associated gastric cancer...
17.
Yuan T, Zeng C, Liu J, Zhao C, Ge F, Li Y, et al.
Signal Transduct Target Ther
. 2024 Jan;
9(1):11.
PMID: 38177135
Non-small cell lung cancer (NSCLC) ranks as one of the leading causes of cancer-related deaths worldwide. Despite the prominence and effectiveness of kinase-target therapies in NSCLC treatment, these drugs are...
18.
Zhang J, Chen X, Ma S
Zhongguo Fei Ai Za Zhi
. 2023 Nov;
26(10):789-794.
PMID: 37989342
The era of tumor treatment has been revolutionized by the advent of immune checkpoint inhibitors. However, while immunotherapy benefits patients, it can also lead to immune-related adverse events that may...
19.
Pu X, Xu C, Wang Q, Wang W, Wu F, Cai X, et al.
Thorac Cancer
. 2023 Sep;
14(31):3166-3177.
PMID: 37718634
The rearranged during transfection (RET) gene is one of the receptor tyrosine kinases and cell-surface molecules responsible for transmitting signals that regulate cell growth and differentiation. In non-small cell lung...
20.
Zhang S, He S, Zhu X, Wang Y, Xie Q, Song X, et al.
Nat Commun
. 2023 Sep;
14(1):5686.
PMID: 37709764
Identifying the primary site of metastatic cancer is critical to guiding the subsequent treatment. Approximately 3-9% of metastatic patients are diagnosed with cancer of unknown primary sites (CUP) even after...